openPR Logo
Press release

Stem cell umbilical cord blood market has billion dollar ($56.4 billion) boom by 2020 with a CAGR of 33.4%.

04-24-2019 08:42 PM CET | Health & Medicine

Press release from: Allied Market Research

Stem cell umbilical cord blood market has billion dollar ($56.4

Allied Market Research today announced the most comprehensive and strategically analyzed report titled World Stem Cell Umbilical Cord Blood (UCB) Market (Storage Services, Therapeutics, Applications, and Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012 - 2020"

Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/114?utm_source=openpr&utm_medium=Niranjan

The study observed that the global umbilical cord blood stem cell market is forecasted to reach a market value of over $11.5 billion in 2014 from $ 6.5billion in 2012. Developments and approvals for novel cord blood stem cells therapies are expected to drive the market growth. The market is expected to reach revenue of $56.4 billion by 2020, growing at CAGR of 33.4% from 2013 to 2020. The storage service market was valued at $7.4billion in 2013.

Increase in the prevalence rate of chronic diseases such as cancer, diabetes, blood disease, immune disease, metabolic disease, etc. Has increased the need for a cost-effective and efficient way of treatment. However, cord blood stem cells have the potential to treat these chronic diseases effectively. These stem cells have the special property of higher cell count in lower blood volume. Collection of these stem cells is much easier than other stem cells and could be stored in specialized preservation facilities called Cord Blood Stem Cell Banks.

Cord blood stem cells market is in its emerging phase. Significant applications of stem cells in the treatment of various disorders will be commercialized very soon as most of them are in the last phase of clinical trials. Patents for collection techniques and therapeutics methods are approved by respective government of developed countries, however, patents for UCB stem cells are comparatively less in developing economies.

Purchase Inquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/114?utm_source=openpr&utm_medium=Niranjan

According to lead analyst Debbie Shields, the geographic analysis shows that the North American market for cord blood stem cell would account for approx. 44% of the total revenue generated by the cord blood market in 2013. However, much-expected growth is to occur in Asia-Pacific regions during the forecast period, because of a growing demand for chronic disease treatments and widely increasing awareness levels.

This report study offers an updated review about major market players present in this market such as researcher based pharmaceutical companies and therapeutics services companies. Company profiles in this report include - Advanced Cell Technology Inc., California Stem Cell Inc., Cytori Therapeutics Inc., Mesoblast Limited, Opexa Therapeutics Inc.(USA), Athersys Inc., Geron Corporation, and Neostem Inc.

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stem cell umbilical cord blood market has billion dollar ($56.4 billion) boom by 2020 with a CAGR of 33.4%. here

News-ID: 1716766 • Views: 532

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Stem

Stem Cell Industry - Exclusive Interviews with Stem Cell Industry Executives
MarketResearchReports.Biz adds “Global Stem Cell Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Stem Cell and the growth estimates for the forecasted period. Stem cell research has been in process for over five decades. Stem cells have a unique ability to divide and replicate repeatedly, as well as an “unspecialized” nature that allows them to differentiate into a
Autologous Stem Cell and Non-Stem Cell Based Therapies Market
Autologous stem-cell transplantation (also known as autogeneic, autogenic, or autogenous stem-cell transplantation or auto-SCT) is the autologous transplantation of stem cells—which is, transplantation in which the undifferentiated cells or stem cells (cells from which other types of cells develop) are taken from a person, accumulated, and given back to the same person later. Even though it is most often executed by means of hematopoietic stem cells (antecedent of cells that
Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell …
Researchmoz added Most up-to-date research on "Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell, Embryonic Stem Cell & Adult Stem Cell" to its huge collection of research reports. In this report, the global Stem Cell Storage market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between
Hematopoietic Stem Cell Transplantation Industry Share Report
Global Hematopoietic Stem Cell Transplantation (HSCT) Market: Snapshot The global market hematopoietic stem cell transplantation (HSCT) has been witnessing a high rise in its valuation and size over the last few years and is anticipated to remain doing so over the next few years. The considerable rise in the geriatric population and the increasing prevalence of non-communicable diseases is the key driving force behind the growth of this market. The increasing
Proceeding of Stem Cells in Asia-Pacific Stem Cell Market.
Asia-Pacific Stem Cell Market research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 15.5% to reach USD 7.15 billion by 2021, from USD 3.48 billion in 2016, which amounts to a cumulative growth of USD 3.67 billion. Stem cells are those cells that are maintained for a long time by remaining undifferentiated and sustained proliferation in a few parts of the body. Stem
STEM Summer Camp 2017
Join Mental Fitness for our second annual Summer of STEAM camp in South Fulton County. Our campers continue their learning in a fun and engaging way while still enjoying the summer! Your student will experience a half day of hands-on project based learning and a half day of good old fashion summer fun. High level concepts like electricity and magnetism, computer coding, environmental projects and more.